The entry of Zydus subsidiary into asset purchase agreement will enable Zydus to manufacture and distribute generic controlled substances in the US market, which otherwise cannot be imported.
Zydus Pharmaceutical through its subsidiary Zynesher Pharmaceuticals USA LLC has entered into an agreement to acquire the assets of US-based pharmaceutical company Nesher Pharmaceuticals Inc.
Nesher has considerable expertise in niche therapies which have development or production barriers, such as controlled release medications or DEA-controlled substances.
The broad-based assets purchase agreement includes Nesher’s existing and pipeline ANDAs (Abbreviated New Drug Application), certain manufacturing facilities and a full fledged research and development lab along with certain liabilities.
This will enable Zydus to manufacture and distribute generic controlled substances in the US market, which otherwise cannot be imported. The market for controlled substances medications in the US is estimated at $7 billion.
Pankaj Patel, chairman and managing director of Zydus Cadila said, “The new development will give us access to a difficult-to-develop product pipeline, expertise and infrastructure that will add value to our operations in the US. It will also help strengthen our generic operations in US with technology-distinguished specialty generics.”
The acquired ANDA pipeline comprising 8 existing filings and 5 products under development present a tremendous market potential as they belong to high growth, niche segments which have a combined estimated market size of over $ 2.1 billion.
Nesher operates as the generic subsidiary of KV Pharmaceutical based at St. Louis, Missouri, USA. Thus, it encompasses supply and technical services agreements by which certain products of KV Pharmaceutical will be manufactured by Zynesher Pharmaceuticals USA LLC.
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}